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Attempts to map the genes for psychotic illnesses have
been fraught with problems. Studying why some family
members do not become ill might prove to be a more
successful strategy.
Address: University Department of Psychiatry, Warneford Hospital,
Oxford OX3 7JX, UK.
Current Biology 1999, 9:R326–R328
http://biomednet.com/elecref/09609822009R0326
© Elsevier Science Ltd ISSN 0960-9822
One of the few well accepted pieces of evidence we have
about the biology of psychiatric illnesses is that there is a
genetic component to (almost) all of them, but very little
is yet known about the number of genes, where they are
on the genome or what they are doing to produce illness.
Ten years ago, a breakthrough was announced with a
report in Nature [1] that a gene, or genes, on chromosome
11 was associated with the development of manic depres-
sive psychosis. Manic depressive psychosis, also known
as bipolar affective disorder, is a condition characterized
by debilitating fluctuations in mood. In mania, patients
experience elation or euphoria, which may spill into psy-
chotic grandeur. There is a reduced need for sleep,
boundless optimism and, too often, hopelessly flawed
judgement in the sexual and financial spheres. In depres-
sive episodes, patients experience profound sadness and
a depressed affect of almost painful intensity. Action and
thinking are slowed and there is significant impairment
of concentration and memory. In depression, there may
be persistent thoughts of suicide and as many as 15% 
of patients who require hospitalisation eventually do 
kill themselves. 
It was with heavy hearts that those of us committed to a
scientific psychiatry read, a couple of years later, that the
claim of a breakthrough in manic depressive psychosis was
wrong [2]. It was overturned by the incidence of only a
few new cases in apparently unaffected members of the
original families. This, and other false positive findings in
the field, led to a greater caution among the research com-
munity in their approach to the declaration of positive
results. There was also a wider pessimism. A curious con-
sensus was formed by scientists who thought all psychiatry
unscientific and an anti-psychiatry lobby who still regard
all efforts to be scientific about psychiatry as inhumane. 
The burden of disability that mood disorder imposes
guarantees, however, the importance of the clinical
problem. Cautious enthusiasm for mapping genes for
manic depressive psychosis has been sustained, and a
number of groups have reported linkages to mood disorders
(see Table 1). To put the table in perspective, the standard
measure of the likelihood that a specific chromosomal posi-
tion is linked to a disorder given a set of segregation data,
the ‘log of the odds ratio’ or LOD score, is reckoned to be
significant if it exceeds 3.6. To find significance is not to
establish confidence that a linkage is real, however. Such
studies are simply too small to achieve that, so convincing
evidence for linkage to any one chromosome is still lacking.
The authors of the largest survey — 319 markers on 540
subjects — admitted that no chromosomal area met criteria
for significant or even suggestive linkage [3].
Three years ago Risch and Botstein [4], commenting on a
series of linkage reports for manic depressive psychosis in
Nature Genetics, asked if the field had advanced and
concluded that “compared to other fields to which genet-
ics has been applied, one would have to argue not”. They
suggested that the genetics of manic depressive psychosis
was much more complex than anyone had anticipated.
Genetics can be complex for a number of reasons. In
disorders caused by mutations in a single gene, the situa-
tion can be bad enough; consider the difficulties in under-
standing the inheritance of fragile X syndrome [5,6], or the
complex series of different phenotypes that arise from
mutations of fibroblast growth factor receptors [7]. When
we deal with disorders that are likely to be due to
mutations in more than one gene, the ways in which com-
plexity can arise are legion: there may be different genes
in different populations, different combinations of genes
producing different phenotypes, variable interactions
between genes and environment and so on.
How complex is the genetics of manic depressive
psychosis likely to be? The answer appears to be that it is
very complex indeed. Consider first how the genetic
analyses are done. The basic methodology of genetic
linkage and association studies is to ask what affected indi-
viduals have in common, genetically speaking. Thus, if all
affected individuals share some segment of chromosome 5
and this is rare or non-existent in unaffected individuals,
we have evidence for a gene predisposing to the disorder
somewhere in the shared segment of chromosome 5. 
Perhaps the sole uncontested result from linkage studies
of manic depressive psychosis is that the disorder is not, at
least commonly, the result of a mutation in a single gene.
Assume that mutations in any ten of a hundred different
genes can give rise to the disorder. In outbred popula-
tions, if we picked 200 affected individuals, the chance
that they all have at least one common mutated gene is
very low. Our genetic test is therefore not going to have
much power to detect an effect, unless we study many
thousands of individuals. One way to simplify things is to
study inbred populations, or those where all affected indi-
viduals are genetically related (inhabitants of small islands
tend to attract the interest of geneticists for this reason).
In a population where all affected individuals are
descended from a single progenitor, then all will have the
same set of susceptibility genes.
This is one reason why the Old Order Amish community
in Pennsylvania — who inhabit a virtual island bounded
by their culture — were selected for one of the largest
genome screens undertaken for any disorder. They have
large extended families with well-documented genealo-
gies dating back to the 30 progenitors who arrived from
Europe in the 18th century. All affected pedigrees trace
back to a very small number of individuals with the disor-
der (perhaps even a single affected founder). Despite such
remarkably propitious circumstances for a gene hunt, the
results have been disappointing: no single chromosome
region stands out as a convincing place to look for the
genes that predispose to this psychiatric illness. This is
why Risch and Botstein [4] concluded that the genetics of
manic depressive psychosis are complex.
There is now a new twist to the Amish story. Hitherto, no
one has thought to look at the absence of illness as a
genetically determined trait in high risk families. Why
not see what the well relatives have in common, geneti-
cally speaking? You might think, from the arguments
given above, that such a strategy would only make things
more complicated. If finding evidence of genetic suscep-
tibility for manic depressive psychosis is complex, then
surely finding evidence of genetic predisposition to
health will be equally complex? Yet the results indicate
otherwise [8]. 
Ginns et al. [8] have recently reported evidence of linkage
to good mental health at a locus on chromosome 4p, with a
P value in favour of linkage of 5.22 × 10–4 (LOD score of
4.05), and a locus on chromosome 4q, with a P value of
2.57 × 10–4 (LOD score of 3.29). In comparison, the most
encouraging result of their search for loci linked to manic
depressive psychosis, in the same population, was one at
chromosome 6p with a LOD score of 2.5. Of course, the
size of the LOD score is not everything: an earlier report
[9] of apparent linkage to Xq28 reported a LOD of 7.5 that
was never replicated. But the new result is certainly more
encouraging than most. Furthermore, the use of simulated
data to obtain empirical P values and an analysis relatively
free of assumptions about the mode of inheritance gives
the result a certain authority.
But why should ‘wellness’ be easier to study than disease?
In families with manic depressive psychosis members,
wellness means either the absence of manic depressive
psychosis predisposing genes, or the presence of protec-
tive alleles. Assuming that the latter is the case, then one
reason why wellness loci have been found might be
because they are rarer than disease loci. In other words, for
the family members studied, health is just a cover-up of
the effects of disease genes. This is not to say that disease
is more common than health within these families: there
may be fewer wellness loci, but each has a larger effect,
and it is this larger effect that has made them easier to
find, relative to disease loci. This would also explain why,
when the investigators increased the age-at-risk cut-off for
defining the wellness phenotype from 25 to 45, the
number of mentally healthy members decreased, while
the P values in favour of linkage increased.
There are certainly plenty of examples of protective alleles
in other conditions: a classic finding in mouse genetics is
that a mutation may lose or radically alter its phenotype
when transferred onto a different genetic background [10]
and similar moderating effects have been reported for a
few complex human disorders ([11] for example). The dis-
covery of protective alleles might make it easier to find the
disease genes. By allowing for the effect of the protective
alleles the genetics of manic depressive psychosis can be
simplified, a little at least. Theoretically, the linkage analy-
ses will have more power to find effects of disease loci.
Studying wellness rather than ill health has other
advantages too. Although linkage of genes for particular
receptors or enzymes to the illness may offer clues to
develop treatments, it might be more fruitful to investi-
gate what neurobiological processes keep individuals well
in high-risk families. Attempts to mimic or stimulate the
molecular actions of the products of such genes might lead
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Table 1
Candidate genetic linkages to mood disorders.
Location LOD Reference Year
Xq28 7.5 [9] 1987
11p15 4.9 [1] 1987
21q22 3.4 [12] 1994
2.76 [13] 1999
12q23 2.1 [14] 1994
18p/18q 2.38 [15] 1994
1.7–3.1 [16] 1995
16p13 2.7 [17] 1995
4p16 4.8 [18] 1996
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to protective treatments that can transform high risk
individuals into low risk individuals. A similar strategy is
already being pursued in relation to apolipoprotein E and
susceptibility to Alzheimer’s dementia. At the very least,
wellness alleles might prove to be predictive of differen-
tial responsiveness to the variety of treatments we already
have. Too often, claims for the molecular genetic
approach to human disease are couched in revolutionary
terms: there is much reference to new dawns and fresh
horizons. To improve the modest benefits of existing
treatment would actually represent a major public health
gain. Let us look forward to it being achieved, along with
more breakthroughs, of course. 
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